| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |